Pfizer Ventures, also known as Pfizer Venture Investments, is a venture capital firm founded in 2004. The firm is a subsidiary of Pfizer. It is based in New York City, New York. As of March 2019, the firm has 45 active companies in its portfolio and has sold off its ownership in 58 companies. Its most recent investment is in Imara on March 2019, a company developing therapeutics for individuals with sickle cell diseases.
Pfizer Ventures focuses on funding companies in the field of bio-pharmaceuticals and neuroscience. The firm primarily seeks to fund companies that are based in the United States, although it also allocates 20% of its investments for non-U.S. companies. It finances companies at various stages, from early to growth. Since its conception, it has managed to collect $600 million from one funding round held in June 2018.
A protein analysis company developing products and systems to analyze protein
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
4D Molecular Therapeutics designs, develops and commercializes products for gene therapy.
SpringWorks Therapeutics is a Stamford, Connecticut-based company.
Arkuda Therapeutics is a Cambridge, Massachusetts-based company.
NeuMoDx Molecular is an Ann Arbor, Michigan-based company.
Palleon Pharmaceuticals is a Waltham, Massachusetts-based company.
Vice President/Senior Managing Partner
Vice President/Managing Partner
Vice President/Senior Partner
Documentaries, videos and podcasts
4D Molecular Therapeutics